Heron Therapeuti Stock Filter Stocks by Fundamentals
HRTX Stock | USD 2.77 0.03 1.09% |
Heron Therapeuti fundamentals help investors to digest information that contributes to Heron Therapeuti's financial success or failures. It also enables traders to predict the movement of Heron Stock. The fundamental analysis module provides a way to measure Heron Therapeuti's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Heron Therapeuti stock.
Price To Book Ratio is likely to rise to -6.57 in 2024. Heron | Price to Book |
Heron Price to Book Analysis
2021 | 2022 | 2023 | 2024 (projected) | Short and Long Term Debt Total | 159.5M | 157.5M | 179.6M | 188.6M | Total Assets | 305.7M | 251.0M | 222.5M | 233.6M |
Heron Price to Book Driver Correlations
Understanding the fundamental principles of building solid financial models for Heron Therapeuti is extremely important. It helps to project a fair market value of Heron Stock properly, considering its historical fundamentals such as Price to Book. Since Heron Therapeuti's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Heron Therapeuti's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Heron Therapeuti's interrelated accounts and indicators.
Click cells to compare fundamentals
Competition |
Heron Price Book Value Ratio
Price Book Value Ratio |
|
Based on the latest financial disclosure, the price to book indicator of Heron Therapeuti is roughly 0.0null. This indicator is about the same for the Biotechnology average (which is currently at 0.0) sector and about the same as Price to Book (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).
Did you try this?
Run Volatility Analysis Now
Volatility AnalysisGet historical volatility and risk analysis based on latest market data |
All Next | Launch Module |
Heron Fundamentals
Return On Equity | -24.09 | ||||
Return On Asset | -0.25 | ||||
Profit Margin | (0.87) % | ||||
Operating Margin | (0.28) % | ||||
Current Valuation | 511.12 M | ||||
Shares Outstanding | 150.33 M | ||||
Shares Owned By Insiders | 0.80 % | ||||
Shares Owned By Institutions | 76.09 % | ||||
Number Of Shares Shorted | 25.43 M | ||||
Price To Earning | (5.15) X | ||||
Price To Book | 12.60 X | ||||
Price To Sales | 3.24 X | ||||
Revenue | 127.04 M | ||||
Gross Profit | (50.51 M) | ||||
EBITDA | (107.72 M) | ||||
Net Income | (110.56 M) | ||||
Cash And Equivalents | 83.54 M | ||||
Cash Per Share | 0.81 X | ||||
Total Debt | 179.63 M | ||||
Debt To Equity | 6.64 % | ||||
Current Ratio | 1.77 X | ||||
Book Value Per Share | (0.23) X | ||||
Cash Flow From Operations | (58.79 M) | ||||
Short Ratio | 8.61 X | ||||
Earnings Per Share | (0.80) X | ||||
Price To Earnings To Growth | (0.18) X | ||||
Target Price | 7.0 | ||||
Number Of Employees | 126 | ||||
Beta | 1.68 | ||||
Market Capitalization | 411.9 M | ||||
Total Asset | 222.51 M | ||||
Retained Earnings | (1.91 B) | ||||
Working Capital | 109.09 M | ||||
Current Asset | 134.75 M | ||||
Current Liabilities | 19.73 M | ||||
Z Score | -11.06 | ||||
Net Asset | 222.51 M |
About Heron Therapeuti Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Heron Therapeuti's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Heron Therapeuti using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Heron Therapeuti based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Last Reported | Projected for 2024 | ||
Price To Book Ratio | (6.91) | (6.57) |
Heron Therapeuti Investors Sentiment
The influence of Heron Therapeuti's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Heron. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Heron Therapeuti's public news can be used to forecast risks associated with an investment in Heron. The trend in average sentiment can be used to explain how an investor holding Heron can time the market purely based on public headlines and social activities around Heron Therapeuti. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Heron Therapeuti's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Heron Therapeuti's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Heron Therapeuti's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Heron Therapeuti.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Heron Therapeuti in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Heron Therapeuti's short interest history, or implied volatility extrapolated from Heron Therapeuti options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Heron Therapeuti Piotroski F Score and Heron Therapeuti Altman Z Score analysis. For more information on how to buy Heron Stock please use our How to Invest in Heron Therapeuti guide.You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Complementary Tools for Heron Stock analysis
When running Heron Therapeuti's price analysis, check to measure Heron Therapeuti's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Heron Therapeuti is operating at the current time. Most of Heron Therapeuti's value examination focuses on studying past and present price action to predict the probability of Heron Therapeuti's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Heron Therapeuti's price. Additionally, you may evaluate how the addition of Heron Therapeuti to your portfolios can decrease your overall portfolio volatility.
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |
Is Heron Therapeuti's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Heron Therapeuti. If investors know Heron will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Heron Therapeuti listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.80) | Revenue Per Share 0.92 | Quarterly Revenue Growth 0.14 | Return On Assets (0.25) | Return On Equity (24.09) |
The market value of Heron Therapeuti is measured differently than its book value, which is the value of Heron that is recorded on the company's balance sheet. Investors also form their own opinion of Heron Therapeuti's value that differs from its market value or its book value, called intrinsic value, which is Heron Therapeuti's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Heron Therapeuti's market value can be influenced by many factors that don't directly affect Heron Therapeuti's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Heron Therapeuti's value and its price as these two are different measures arrived at by different means. Investors typically determine if Heron Therapeuti is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Heron Therapeuti's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.